2008
DOI: 10.1016/j.ejphar.2007.08.035
|View full text |Cite
|
Sign up to set email alerts
|

The effect of taurolidine on experimental thrombus formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 4 publications
0
13
1
Order By: Relevance
“…Although taurolidine has shown to be able to decrease thrombus weight, but is not as effective as heparin in this respect [27], we observed a lowered incidence of catheter related occlusions with its use. Previous studies described a relationship between the number of CRBSI and occlusions, possibly due to infection-induced activation of the coagulation system [28].…”
Section: Discussioncontrasting
confidence: 65%
“…Although taurolidine has shown to be able to decrease thrombus weight, but is not as effective as heparin in this respect [27], we observed a lowered incidence of catheter related occlusions with its use. Previous studies described a relationship between the number of CRBSI and occlusions, possibly due to infection-induced activation of the coagulation system [28].…”
Section: Discussioncontrasting
confidence: 65%
“…Furthermore, SMBE perhaps had some additional effect that prolongs occlusion time beyond what would be expected from the effect on cycloxygenase, or more generally on the synthesis of thromboxane and PGI2, especially for the lower SMBE doses. It is uncertain whether this is related to a differential effect on platelets rather than to actual thrombosis, and therefore needs to be further investigated [23,24].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, CTL perhaps had some additional effect that prolongs occlusion time beyond what would be expected from the effect on cyclo-oxygenase, or more generally on the synthesis of thromboxane and PGI2, especially for the lower CTL doses. It is uncertain whether this is related to a differential effect on platelets rather than to actual thrombosis, and therefore needs to be further investigated [25,26].…”
Section: Discussionmentioning
confidence: 99%